Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 230 of the 234 references it cites were found in a registry or an index; 198 of the 369 sources its claims cite were checked for support.

Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine

Open access

Abstract

Tissue-engineered decellularized extracellular matrix (ECM) scaffolds hold great potential to address the donor shortage as well as immunologic rejection attributed to cells in conventional tissue/organ transplantation. Decellularization, as the key process in manufacturing ECM scaffolds, removes immunogen cell materials and significantly alleviates the immunogenicity and biocompatibility of derived scaffolds. However, the application of these bioscaffolds still confronts major immunologic challenges. This review discusses the interplay between damage-associated molecular patterns (DAMPs) and antigens as the main inducers of innate and adaptive immunity to aid in manufacturing biocompatible grafts with desirable immunogenicity. It also appraises the impact of various decellularization methodologies (i.e., apoptosis-assisted techniques) on provoking immune responses that participate in rejecting allogenic and xenogeneic decellularized scaffolds. In addition, the key research findings regarding the contribution of ECM alterations, cytotoxicity issues, graft sourcing, and implantation site to the immunogenicity of decellularized tissues/organs are comprehensively considered. Finally, it discusses practical solutions to overcome immunogenicity, including antigen masking by crosslinking, sterilization optimization, and antigen removal techniques such as selective antigen removal and sequential antigen solubilization.

Overview

CoChat Summary

## TL;DR

This review argues that the main barrier to clinical use of decellularized ECM scaffolds is not decellularization itself, but the residual immunogenicity created by leftover antigens, DAMPs, ECM damage, source tissue differences, implantation site, and processing residues. It surveys decellularization, antigen-removal, crosslinking, and sterilization strategies to reduce immune rejection and improve recellularization.

## Key findings

  • Decellularization is defined here as removing DNA and other cellular materials while preserving ECM; competent decellularization should show no visible nuclei on H&E/DAPI and keep residual dsDNA below 50 ng per dry weight and 200 bp length.
  • Incomplete or harsh decellularization can increase immunogenicity by leaving cell remnants and by damaging ECM, exposing cryptic epitopes, reducing GAGs/growth factors, and impairing recellularization.
  • The paper identifies major contributors to dECM immunogenicity as decellularization efficiency/method, ECM alteration, tissue or organ source, implantation site, and recipient features.
  • It reports several example thresholds and outcomes: residual SDS > 50 mg/L in washing solution or >10 µg/mg dry weight in ECM is described as cytotoxic; 15 mM remaining TX100 is cited as tolerated by human cell lines; 25 kGy is presented as the optimal gamma dose for sterilization with minimal immune response.

## Methods

  • Narrative review of the literature on decellularized extracellular matrix scaffold immunogenicity, with sections organized around immune mechanisms, sources of immunogenicity, and mitigation strategies.
  • Synthesizes published studies across tissues/organs and processing methods, including physical, chemical, and biological decellularization approaches, plus post-processing interventions such as antigen removal, crosslinking, and sterilization.
  • Main analysis is conceptual and comparative: it contrasts how specific processing choices and tissue sources affect antigen retention, ECM integrity, DAMP release, and downstream innate/adaptive immune responses.

## Limitations

  • The paper is a review and does not present a single new experimental dataset or meta-analysis with pooled effect sizes; this is evident from the text.
  • It explicitly notes that there is “no consensus” on accepting the cited decellularization criteria as a standard to predict scaffold immunogenicity.
  • Several areas are stated as unresolved or needing future work, including how decellularization affects hyaluronic acid/GAG structure, which sterilization method is best for each tissue, and how to define a standard for acceptable immunogenicity.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40824-023-00348-z

Cites

230 of 230 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Innate and adaptive immune response against dECM scaffolds. (1) Decellularization strategies inevitably produce various amounts of damage-associated molecular patterns (DAMPs), which trigger pattern recognition receptors (PRRs) on innate immune cells. (2) Stimulation of PRRs in antigen-presenting cells provides prerequisites of T cell activation, including pro-inflammatory cytokine and major histocompatibility complex and co-stimulatory molecules, as well as triggering complement cascade to produce C3a, C3b, and C5a. T cell activation is the essential trigger for B cells, which mediate antibody production against remaining antigens within dECM scaffolds. Antigen-antibody interactions further trigger complement cascades and implement a vicious cycle. (3) C3a and C5a recruit immune cells and induce T helper type 1 (TH1) and TH17 polarization in helper CD4+ T cells, increasing the production of pro-inflammatory cytokines. (4) Elevation of pro-inflammatory cytokine content in the implantation site leads to further recruitment of immune cells and induces M1 polarization in naïve macrophages. (5) C3b complements enhance matrix metalloproteinases (MMP) production in M1 macrophages, accelerating the decellularized extracellular matrix (dECM) scaffold degradation and failure
Fig. 1 Innate and adaptive immune response against dECM scaffolds. (1) Decellularization strategies inevitably produce various amounts of damage-associated molecular patterns (DAMPs), which trigger pattern recognition receptors (PRRs) on innate immune cells. (2) Stimulation of PRRs in antigen-presenting cells provides prerequisites of T cell activation, including pro-inflammatory cytokine and major histocompatibility complex and co-stimulatory molecules, as well as triggering complement cascade to produce C3a, C3b, and C5a. T cell activation is the essential trigger for B cells, which mediate antibody production against remaining antigens within dECM scaffolds. Antigen-antibody interactions further trigger complement cascades and implement a vicious cycle. (3) C3a and C5a recruit immune cells and induce T helper type 1 (TH1) and TH17 polarization in helper CD4+ T cells, increasing the production of pro-inflammatory cytokines. (4) Elevation of pro-inflammatory cytokine content in the implantation site leads to further recruitment of immune cells and induces M1 polarization in naïve macrophages. (5) C3b complements enhance matrix metalloproteinases (MMP) production in M1 macrophages, accelerating the decellularized extracellular matrix (dECM) scaffold degradation and failureCC BY · PubMed Central
Fig. 2 ECM alterations and immune response. Decellularization-derived damages to the extracellular matrix affect its immunogenicity via exposing/producing immunogenic particles or depleting immunomodulatory molecules. (1) Decellularization may destroy immunosuppressive traits of high molecular weight hyaluronic acids (HMWHAs) by breaking them into low molecular weight hyaluronic acids (LMWHAs). HMWHAs induce a regulatory phenotype in T cells and macrophages while suppressing humoral immunity and dendritic cell maturation. (2) LMWHAs are demonstrated to interact with CD44 and toll-like receptors of leukocytes and invoke inflammatory responses such as enhancing leukocyte chemotaxis, dendritic cell maturation and polarization of naïve macrophages toward M1 phenotype. (3) Collagen denaturation during decellularization may expose some cryptic antigenic sites and trigger antibody production, or (4) upregulate immune system activity through the depletion of RGD motives, which impede leucocytes chemotaxis and take part in the M2 polarization of macrophages. (5) Elastin particles are released upon elastin damage and provoke monocyte chemotaxis, antibody-mediated immune response, and T helper cell differentiation toward inflammatory phenotypes
Fig. 2 ECM alterations and immune response. Decellularization-derived damages to the extracellular matrix affect its immunogenicity via exposing/producing immunogenic particles or depleting immunomodulatory molecules. (1) Decellularization may destroy immunosuppressive traits of high molecular weight hyaluronic acids (HMWHAs) by breaking them into low molecular weight hyaluronic acids (LMWHAs). HMWHAs induce a regulatory phenotype in T cells and macrophages while suppressing humoral immunity and dendritic cell maturation. (2) LMWHAs are demonstrated to interact with CD44 and toll-like receptors of leukocytes and invoke inflammatory responses such as enhancing leukocyte chemotaxis, dendritic cell maturation and polarization of naïve macrophages toward M1 phenotype. (3) Collagen denaturation during decellularization may expose some cryptic antigenic sites and trigger antibody production, or (4) upregulate immune system activity through the depletion of RGD motives, which impede leucocytes chemotaxis and take part in the M2 polarization of macrophages. (5) Elastin particles are released upon elastin damage and provoke monocyte chemotaxis, antibody-mediated immune response, and T helper cell differentiation toward inflammatory phenotypesCC BY · PubMed Central
Fig. 3 Apoptosis and necrosis as the core mechanisms of cell death in decellularization. Necrosis or apoptosis is the ultimate fate of cells upon the decellularization process. A Cell necrosis resulting from applying conventional decellularization techniques drives the vast leakage of immunogenic cellular materials, which invokes inflammatory responses following the implantation of derived scaffolds. B Apoptosis-assisted decellularization techniques exploit environmental stresses (extrinsic pathway) or death ligands to induce apoptosis. Following apoptosis, immunogenic cellular contents are degraded and confined to membranous vesicles that exert an immunomodulatory response
Fig. 3 Apoptosis and necrosis as the core mechanisms of cell death in decellularization. Necrosis or apoptosis is the ultimate fate of cells upon the decellularization process. A Cell necrosis resulting from applying conventional decellularization techniques drives the vast leakage of immunogenic cellular materials, which invokes inflammatory responses following the implantation of derived scaffolds. B Apoptosis-assisted decellularization techniques exploit environmental stresses (extrinsic pathway) or death ligands to induce apoptosis. Following apoptosis, immunogenic cellular contents are degraded and confined to membranous vesicles that exert an immunomodulatory responseCC BY · PubMed Central
Fig. 4 Common post-decellularization modifications to address the immunogenicity of dECM scaffolds. A Selective antigen removal techniques rely on enzymatic treatment to specifically remove antigens (i.e., α-gal, Neu5Gc, and Sda epitopes). B Crosslinking may reduce the immunogenicity of dECM by masking exposed antigenic sites. C Solubilization removes various protein antigens (hydrophobic and hydrophilic antigens) according to their common physiochemical properties. D Terminal sterilization eliminates pathogen-related immunogenicity of viruses and bacteria in the dECM scaffolds
Fig. 4 Common post-decellularization modifications to address the immunogenicity of dECM scaffolds. A Selective antigen removal techniques rely on enzymatic treatment to specifically remove antigens (i.e., α-gal, Neu5Gc, and Sda epitopes). B Crosslinking may reduce the immunogenicity of dECM by masking exposed antigenic sites. C Solubilization removes various protein antigens (hydrophobic and hydrophilic antigens) according to their common physiochemical properties. D Terminal sterilization eliminates pathogen-related immunogenicity of viruses and bacteria in the dECM scaffoldsCC BY · PubMed Central

Verification

Claims the paper makes

157 Valid · 3 Not valid · 87 Not checked · 23 Own results and interpretations

136 more claims · 79 with their cited sources checked

Create a free account to see all 270 claims and to verify the 42 references still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 115

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 234 references

Cited by

See all 316

Metadata

Authors
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H.
Affiliations
  • Research Institute for Gastroenterology and Liver Diseases (IR)
  • Shahid Beheshti University (IR)
  • University of California, Los Angeles (US)
  • Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA (AT)
Corresponding author
Niknejad, Hassan
Venue
Biomaterials Research
Published
2023-02-09
Volume
27
Issue
1
Pages
10-10
ISSN
  • 1226-4601 (ISSN-L)
  • 2055-7124
OpenAlex
W4319722881
Cited by
316
References
234
Citations by year
2026: 85 · 2025: 125 · 2024: 69 · 2023: 37
FWCI
20.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Biomaterials Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute for Medical Research Development (963951)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
Keywords
immunogenicity, damage-associated molecular patterns, innate immunity, adaptive immunity, decellularization methods, allograft rejection, xenograft rejection, antigen masking, crosslinking, sterilization, implantation site, cytotoxicity, biocompatibility

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine. https://app.cochat.ai/papers/10.1186/s40824-023-00348-z
The paper
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H. (2023). Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine. Biomaterials Research. https://doi.org/10.1186/s40824-023-00348-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.